Related Experiment Videos
Unpredictable response to vasodilator therapy in primary pulmonary hypertension
M I Schmiedt1, U R Shettigar, M Siddique
1VA Medical Center, University of South Florida College of Medicine, Bay Pines 33744, USA.
International Journal of Clinical Pharmacology and Therapeutics
|September 3, 1998
Summary
Isoproterenol offered temporary relief for severe pulmonary hypertension but led to dependence and a fatal outcome. Careful hemodynamic monitoring is crucial for unpredictable vasodilator responses in primary pulmonary hypertension.
Area of Science:
- Cardiology
- Pulmonary Medicine
- Pharmacology
Background:
- Severe primary pulmonary hypertension (PPH) presents a significant therapeutic challenge, often showing limited response to conventional vasodilators.
- The unpredictable nature of vasodilator efficacy in PPH necessitates careful evaluation of treatment responses.
Observation:
- A patient with severe PPH, unresponsive to multiple vasodilators, experienced hemodynamic improvement with intravenous isoproterenol.
- This included reduced pulmonary vascular resistance and increased cardiac output, indicating a beneficial acute effect.
Findings:
- Despite initial benefits, the patient developed dependence on intravenous isoproterenol.
- Sudden death occurred due to bradyarrhythmia, with autopsy confirming severe primary pulmonary hypertension.
Implications:
- This case highlights the potential for isoproterenol to induce dependence in PPH management.
- Sequential hemodynamic assessment is vital to identify optimal and safe vasodilator strategies for PPH.
- The unpredictable response to vasodilators underscores the need for individualized treatment approaches.